Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | FRAX1036 |
| Trade Name | |
| Synonyms | FRAX-1036 |
| Drug Descriptions |
FRAX1036 is an inhibitor of group I PAKs (PAK1, PAK2, and PAK3), which may result in increased tumor cell apoptosis and sensitivity to microtubule-targeted agents (PMID: 25902869). |
| DrugClasses | PAK1 Inhibitor 11 |
| CAS Registry Number | 1432908-05-8 |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| BDP9066 + FRAX1036 | BDP9066 FRAX1036 | 0 | 0 |
| Docetaxel + FRAX1036 | Docetaxel FRAX1036 | 0 | 0 |
| Everolimus + FRAX1036 | Everolimus FRAX1036 | 0 | 0 |
| FRAX1036 | FRAX1036 | 0 | 0 |
| FRAX1036 + Lenvatinib | FRAX1036 Lenvatinib | 0 | 0 |